Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daisuke Yabe

Showing results (111-120 of 253) with videos related to

Pageof 26
Sort By:
Journal of Diabetes Investigation|October 4, 2024
The Ulaanbaatar agreement: Revising diabetes terminology in Asia to combat stigmaYutaka Seino, Daisuke Yabe, Kazuhiro Tsumura, et al.
Nutrients|September 9, 2023
Oral Semaglutide under Human Protocols and Doses Regulates Food Intake, Body Weight, and Glycemia in Diet-Induced Obese MiceYermek Rakhat, Lei Wang, Wanxin Han, et al.
Diabetes, Obesity & Metabolism|March 16, 2017
Efficacy and safety of sitagliptin as compared with glimepiride in Japanese patients with type 2 diabetes mellitus aged ≥ 60 years (START-J trial)Yasuo Terauchi, Yuichiro Yamada, Hitoshi Ishida, et al.
BMJ Open|April 8, 2021
Rationale and design of the EMPA-ELDERLY trial: a randomised, double-blind, placebo-controlled, 52-week clinical trial of the efficacy and safety of the sodium-glucose cotransporter-2 inhibitor empagliflozin in elderly Japanese patients with type 2 diabetesDaisuke Yabe, Kosuke Shiki, Keiko Suzaki, et al.
Endocrinology, Diabetes & Metabolism Case Reports|August 13, 2025
Decreased β-cell function in a case with Becker muscular dystrophy accompanied by post-transplant diabetesKazuya Motohashi, Takaaki Murakami, Daisuke Otani, et al.
Diabetology International|August 5, 2024
A case of insulinoma misidentified as schizophrenia due to its manifestation in neuropsychiatric symptomsTomoyuki Haba, Kengo Yamakawa, Sayako Ozeki, et al.
The Journal of Clinical Endocrinology and Metabolism|August 19, 2023
Effect of Roxadustat on Thyroid Function in Patients With Renal AnemiaTakuya Haraguchi, Yoshiyuki Hamamoto, Hitoshi Kuwata, et al.
Diabetology International|March 25, 2020
Correction to: Japanese Clinical Practice Guideline for Diabetes 2016Masakazu Haneda, Mitsuhiko Noda, Hideki Origasa, et al.
Endocrine Journal|October 5, 2022
Increased expression of glucagon-like peptide-1 and cystic fibrosis transmembrane conductance regulator in the ileum and colon in mouse treated with metforminMomoka Mizoguchi, Hiroshi Takemori, Saho Furukawa, et al.
Frontiers in Clinical Diabetes and Healthcare|October 3, 2025
Association between eating behavior patterns and the therapeutic efficacy of GLP-1 receptor agonists in individuals with type 2 diabetes: a multicenter prospective observational studyYuya Koide, Takehiro Kato, Makoto Hayashi, et al.
Pageof 26

Showing results (111-120 of 253) with videos related to

Sort By:
Pageof 26
Journal of Diabetes Investigation|October 4, 2024
The Ulaanbaatar agreement: Revising diabetes terminology in Asia to combat stigmaYutaka Seino, Daisuke Yabe, Kazuhiro Tsumura, et al.
Nutrients|September 9, 2023
Oral Semaglutide under Human Protocols and Doses Regulates Food Intake, Body Weight, and Glycemia in Diet-Induced Obese MiceYermek Rakhat, Lei Wang, Wanxin Han, et al.
Diabetes, Obesity & Metabolism|March 16, 2017
Efficacy and safety of sitagliptin as compared with glimepiride in Japanese patients with type 2 diabetes mellitus aged ≥ 60 years (START-J trial)Yasuo Terauchi, Yuichiro Yamada, Hitoshi Ishida, et al.
BMJ Open|April 8, 2021
Rationale and design of the EMPA-ELDERLY trial: a randomised, double-blind, placebo-controlled, 52-week clinical trial of the efficacy and safety of the sodium-glucose cotransporter-2 inhibitor empagliflozin in elderly Japanese patients with type 2 diabetesDaisuke Yabe, Kosuke Shiki, Keiko Suzaki, et al.
Endocrinology, Diabetes & Metabolism Case Reports|August 13, 2025
Decreased β-cell function in a case with Becker muscular dystrophy accompanied by post-transplant diabetesKazuya Motohashi, Takaaki Murakami, Daisuke Otani, et al.
Diabetology International|August 5, 2024
A case of insulinoma misidentified as schizophrenia due to its manifestation in neuropsychiatric symptomsTomoyuki Haba, Kengo Yamakawa, Sayako Ozeki, et al.
The Journal of Clinical Endocrinology and Metabolism|August 19, 2023
Effect of Roxadustat on Thyroid Function in Patients With Renal AnemiaTakuya Haraguchi, Yoshiyuki Hamamoto, Hitoshi Kuwata, et al.
Diabetology International|March 25, 2020
Correction to: Japanese Clinical Practice Guideline for Diabetes 2016Masakazu Haneda, Mitsuhiko Noda, Hideki Origasa, et al.
Endocrine Journal|October 5, 2022
Increased expression of glucagon-like peptide-1 and cystic fibrosis transmembrane conductance regulator in the ileum and colon in mouse treated with metforminMomoka Mizoguchi, Hiroshi Takemori, Saho Furukawa, et al.
Frontiers in Clinical Diabetes and Healthcare|October 3, 2025
Association between eating behavior patterns and the therapeutic efficacy of GLP-1 receptor agonists in individuals with type 2 diabetes: a multicenter prospective observational studyYuya Koide, Takehiro Kato, Makoto Hayashi, et al.
Pageof 26